Ambase Corp (OTCMKTS:ABCP): Brian Sheehy’s Iszo Capital filed an amended 13D.
You can check out Iszo Capital’s latest holdings and filings here.
Please follow Iszo Capital (if you aren’t already doing so) to get real-time email alerts whenever we publish an article about Iszo Capital or update its stock holdings.
Brian Sheehy
Iszo Capital We may use your email to send marketing emails about our services. Click here to read our privacy policy.
You can access the original SEC filing by clicking here.
Ownership Summary Table
| Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
|---|---|---|---|---|---|---|
| IsZo Capital | 0 | 8,675,951 | 0 | 8,675,951 | 8,675,951 | 21.3% |
| IsZo Capital GP | 0 | 8,675,951 | 0 | 8,675,951 | 8,675,951 | 21.3% |
| IsZo Capital Management | 0 | 8,675,951 | 0 | 8,675,951 | 8,675,951 | 21.3% |
| Brian L. Sheehy | 0 | 8,675,951 | 0 | 8,675,951 | 8,675,951 | 21.3% |
Brian Sheehy
Iszo Capital We may use your email to send marketing emails about our services. Click here to read our privacy policy.
Page 1 of 12 – SEC Filing
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No.___)
AmBase Corp.
(Name of Issuer)
Class A Common Stock, par value $0.01
(Title of Class of Securities)
0231647106
(CUSIP Number)
Brian L. Sheehy
IsZo Capital Management LP
415 Madison Avenue, 14th Floor
New York, NY 10017
Tel: 646-775-4394
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
October 23, 2017
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Sections 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box [x]
*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (the “Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act.
Follow Ambase Corp (OTCMKTS:ABCP)Follow Ambase Corp (OTCMKTS:ABCP)
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
Page 1 of 12
DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks
Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.
If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.
Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.
Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
Related Insider Monkey Articles
13D Filing: RA Capital Management and Kalvista Pharmaceuticals Inc. (KALV)
13D Filing: Elliott Associates, L.P. and Cormedix Inc. (CRMD)
13D Filing: JANA Partners and EQT Corp (EQT)
13D Filing: Engine Capital, L.P. and PFSweb, Inc. (PFSW)
13D Filing: James E. Flynn and AveXis Inc (AVXS)
13D Filing: Delta Partners and Good Times Restaurants Inc. (GTIM)
